Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
NextGen Therapeutics
Regeneron’s New Bispecific: A Toxic Success?
Regeneron announced that their bispecific odronextamab had the highest recorded complete response rate for follicular lymphoma, but the therapeutic antibody’s safety profile has thrown up several concerns.
Dual-Action Malaria Vaccine Takes the Punch out of the Parasite
A new vaccine duo developed by scientists at George Washington University stops malaria infection and transmission, the double attack needed to eradicate the disease.
Drug Discovery & Development
What are the Key Challenges in Developing Bispecific Antibodies for Cancer Immunotherapy?
Are there too many opportunities in antibody-based immunotherapy? How do you choose your targets? How do you know when to kill a project?
Nexelis’s Collaborative Development for Optimal Clinical Assay
November’s webinar, Adaptive Laboratory Environment: Collaboration Across our Development Teams Produces Optimal Clinical Assay, discusses Nexelis’s process in recombinant protein production, optimisation, and characterisation.
Manufacturing & Bioprocessing
Q &A with Shilpi Rajoria
An interview Shilpi Rajoria, Director QC Analytical Testing at Bristol Myers Squibb.
Vaccines
Overcoming Vaccine Manufacturing Challenges
Experts from King’s College London, Janssen, and Merck Sharp & Dohme congregate to talk the future of optimised vaccine manufacturing.
3D Cell Culture
Understanding the Capabilities of 3D Bioprinting for Cell and Gene Therapy
Exploring academic perspectives on 3D bioprinting techniques for cancer and disease indication models.
Vaccines After COVID: How the Pandemic Has Changed the Vaccination Market
During the pandemic, a layperson couldn't avoid learning about vaccinations. But as the world returns to “normal”, how does this new-found focus on vaccines manifest for regulators, producers, prescribers, and the public?
3D Cell Culture
Advanced and Predictive 3D Cell Culture Models
Elodie Vandenhaute, Project Director at HCS Pharma, leads a discussion group on utilising multi-cell type models to understand diseases, cells, and therapeutic mechanisms.
Vaccines
Vaccines Europe: Presentations You Won’t Want to Miss
Find out about some of Oxford Global’s most highly anticipated presentations happening at our upcoming Vaccines Congress.
Manufacturing & Bioprocessing
Accelerating Upstream Process Development with Direct CQA and Media Analysis Feedback
Upstream Bioprocess Development.
Immuno-Oncology
Delivering Immuno-Oncology Therapies for Solid Tumours
The panel at Immuno UK 2022 discuss the unique challenges that come with delivering immunotherapies to solid malignancies.